Aptiv reported record fourth-quarter revenue of $5.2 billion, a 3% increase, as the automotive technology leader prepares to spin off its Electrical Distribution Systems business as the independent company Versagen on April 1, 2026.
After years of share price weakness, Immunocore Holdings (IMCR) appears significantly undervalued by traditional metrics. But does the market know something the models don't? We examine the DCF and P/S analyses, the company's unique T-cell receptor platform, and the risks that have kept investors wary.
Comcast announces a major restructuring of its connectivity division, appointing a new CEO, as it navigates a $240 million patent loss and gears up for a pivotal sports streaming season with the Olympics and Super Bowl on the horizon.
Toyota Motor Corp. has cemented its position as the world's top-selling automaker for 2025, posting record global sales fueled by robust demand for its hybrid vehicles. The results underscore the company's strategic bet on a multi-pathway approach to electrification, even as new U.S. tariffs and shifting trade policies challenge the global industry.
A major court judgment tied to a 2021 fatal collision, alongside other vehicle incidents, severely impacted Landstar's fourth-quarter profits, compounding pressures from skyrocketing insurance premiums.
Shoppers are bracing for another wave of price increases as new import taxes take effect, targeting a range of everyday items from spirits to seafood. Experts warn the hikes will squeeze household budgets and force tough choices at the supermarket.
The all-stock deal creates one of the nation's largest independent oil and gas producers, headquartered in Houston, with combined assets poised to reshape the competitive landscape of the shale sector.
As economic pressures mount, flexible remote work opportunities are evolving. We examine four proven side gigs that experts project can still generate significant weekly earnings from home in the coming years.
As Bob Iger prepares for his second departure, the Disney CEO outlines a forward-looking mandate for his successor during an earnings call, emphasizing evolution in a dynamic media landscape.
While investors flock to mass-market and electric vehicle stocks, Ferrari's unique strategy of cultivating scarcity and brand prestige has delivered enviable margins and pricing power. With shares well off their highs, analysts debate if now is the time to buy into this iconic automaker for the long haul.
Freedom Capital initiates coverage on Mama's Creations (MAMA) with a Buy rating and a $16 price target, citing the company's expanding national footprint, product innovation, and strong recent earnings as key growth catalysts in the fresh meal sector.
IDEXX Laboratories reports robust fourth-quarter and full-year 2025 results, with double-digit revenue growth fueled by record instrument placements and strategic innovations like InVue DX and CancerDx. The company provides a confident outlook for 2026, targeting continued organic growth despite sector headwinds.
As the 2026 tax filing deadline approaches, new and expanded federal tax credits and deductions offer significant opportunities for filers to reduce their liability or increase their refund. Experts warn that millions overlook these benefits annually.
Russian pipeline gas exports to Europe via TurkStream increased in January, even as the EU finalizes a sweeping ban and Moscow's overall sales hit a multi-decade low, underscoring the continent's complex and uneven energy transition.
A relentless focus on dividend yield may have led retirees and income investors to overlook one of the market's top performers. The Invesco NASDAQ 100 ETF (QQQM), with its scant 0.51% yield, has delivered over 108% total returns since inception by betting on growth, not income—a stark lesson in opportunity cost.
The Norwegian monarchy is rocked by dual crises as Marius Borg Høiby, son of Crown Princess Mette-Marit, stands trial on serious criminal charges, while newly unsealed Jeffrey Epstein documents reveal extensive past connections to the princess.
Two French infant formula makers have recalled multiple product batches following the government's decision to slash permissible levels of cereulide, a toxin linked to gastrointestinal illness. The move amplifies a global safety crisis that has seen major brands issue recalls across dozens of countries since late last year.
In a joint diplomatic push, Chile, Brazil, and Mexico have officially submitted former Chilean President Michelle Bachelet's candidacy to become the first woman to lead the United Nations, as the race to succeed Antonio Guterres heats up.
For retirees seeking to increase their monthly income, re-entering the workforce may offer a path to higher Social Security payments—with important considerations.
Barclays initiates coverage with an Overweight rating and $20 price target on Altimmune, citing strong fundamentals and pipeline potential. The biotech firm prepares to channel recent offering proceeds toward its pivotal Phase 3 development for metabolic liver disease treatment pemvidutide.
